Altimmune (ALT) will be added to the Nasdaq Biotechnology Index (NBI) effective prior to the market open on Monday, December 23, 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALT:
- Biotech Alert: Searches spiking for these stocks today
- Unusually active option classes on open December 4th
- Altimmune presents data on effect of pemvidutide on inflammatory lipids
- Largest borrow rate increases among liquid names
- Charter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz